Delivery Order SPE2DR25D2103-SPE2DR26F91UL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Erleada 60 mg tablets (120-count units) with a ceiling value of $7,965.80. This firm fixed-price delivery order is set to complete by December 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation, demonstrating AmerisourceBergen's continued capability to...
- The Defense Logistics Agency awarded a $15,496.80 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,496.78 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by December 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,965.80 on December 17, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 9, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,748.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. The award represents a non-competitive delivery order issued under an existing indefinite delivery contract vehicle. Performance will be completed by January 6, 2026, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units, with a contract ceiling value of $7,352.49. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, was competitively awarded without set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,965.80 and is structured as a firm fixed price contract with an ultimate completion date of January 8, 2026. The pharmaceutical product will be delivered to the contracting location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,748.39 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) on December 15, 2025. This firm fixed-price delivery order, which is expected to be completed by January 7, 2026, represents a non-competitively set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Erleada 240 mg tablets (30-unit packages) with a ceiling value of $7,748.39 and firm fixed pricing. The order is scheduled for completion by December 16, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract utilizing firm fixed pricing,...
- SPE2DR25D2103Indefinite Delivery Contract
- SPE2DR25D2103-SPE2DR26F91ULDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Erleada 60 mg tablets (120-count units) with a contract ceiling value of $15,931.60. This is a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems globally. The current order for Erleada, a prescription prostate cancer treatment, exemplifies the company's role in delivering specialized pharmaceutical products to federal healthcare programs, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 12/16/25 |